Kathleen Nemeth
Senior Vice President, Investor Relations
Replay available
Omnicell, Inc. (NASDAQ: OMCL) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.

Senior Vice President, Investor Relations
Chairman, President, CEO, and Founder
Executive Vice President and Chief Financial Officer
Analyst at Piper Sandler
Analyst at Craig Hallam Capital Group
Executive Vice President and Chief Operating Officer
Analyst at Wells Fargo
Analyst at BTIG
Analyst at The Benchmark Company
Analyst at KeyBank Capital Markets
Analyst at Freedom Capital Markets
Analyst at Bank of America
Thank you for standing by. At this time, I would like to welcome everyone to today's OmniCell third quarter 2025 financial results call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. Once again, star one. And if you'd like to withdraw your question, simply press star one again. Thank you. I would now like to turn the call over to Kathleen Nemeth, Senior Vice President, Investor Relations. Kathleen? Good morning, and welcome to the OmniCell Third Quarter 2025 Financial Results Conference Call. On the call with me today are Randall Lipps, OmniCell Chairman, President, CEO, and Founder, and Baird Radford, Executive Vice President and Chief Financial Officer, as well as Nnamdi Njoku, Executive Vice President, and Chief Operating Officer. This call will contain forward-looking statements, including statements related to financial projections or performance and market or company outlook based on current expectations. These forward-looking statements speak only as of today or the date specified on the call. Actual results and other events may differ materially from those contemplated due to numerous factors, that involves substantial risks and uncertainties. For more information, please refer to our press release issued today, OmniCell's annual report on Form 10-K filed with the SEC on February 27, 2025, and in other more recent reports filed with the SEC. Except as required by law, we do not assume any obligation to update any forward-looking statements. During this call, we will discuss some non-GAAP financial measures. Reconciliations of these non-GAAP measu...